Autopsy report · NCT04400890

Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol, a Plant Polyphenol, for COVID-19

“Feasibility”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 6 months before it stopped.
• 105 participants enrolled.
• Results were posted on the registry 2 years after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Marvin McCreary, MD

Sponsor type

University, hospital or other

Conditions

COVID-19

Interventions

Resveratrol; Vitamin D3

Participants

105

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.